Efficacy and safety of Tongxin formula after stent implantation for acute coronary syndrome: A multicenter, double-blind, placebo-controlled randomized trial

•The Tongxin formula significantly reduces the incidence of major adverse cardiovascular events in patients with acute coronary syndromes after coronary stenting, demonstrating a notable improvement in patient outcomes when added to optimal medical therapy.•Patients receiving the Tongxin formula exh...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Explore (New York, N.Y.) N.Y.), 2024-09, Vol.20 (5), p.102992, Article 102992
Hauptverfasser:	Zhu, Wen, Wang, Su, Zhang, Lei, Xie, Feng-Qun, Cheng, Jie, Li, Xian-Kai, Chen, Wei, Yan, Shi-Yun, Feng, Qi-Mao
Format:	Artikel
Sprache:	eng
Schlagworte:	acute coronary syndrome clinical trial percutaneous coronary intervention randomized control Tongxin formula
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!